Certain groups are at an increased risk for serious complications from the flu, including adults 50 years of age and older and those with chronic health conditions. Sanofi's two higher-dose influenza ...

While the flu vaccine is the best way to prepare for flu season, older adults don't have as robust an immune response to the jab as young people do. To address this problem, Sanofi Pasteur formulated ...

The European Commission has kicked off formal proceedings in an antitrust investigation against Sanofi. The probe surrounds ...

Customers will start receiving shipments from July 10 with additional shipments through October to healthcare provider offices, pharmacies and other immunizers to support fall immunization campaigns.

PARIS, Aug 26 (Reuters) - Sanofi said on Monday that a large clinical trial showed its Fluzone High-Dose vaccine to be more effective at preventing influenza in adults aged 65 and older than a ...

BRIDGEWATER, N.J., March 14, 2025 /PRNewswire/ -- Sanofi announced today the immediate adoption of influenza strains selected by the US Food and Drug Administration (FDA) to advance the manufacturing ...